Comparative long-term cardiovascular and hematologic outcomes of gemtuzumab ozogamicin containing regimens versus idarubicin containing regimens in acute promyelocytic leukemia: A propensity-matched analysis of real-world multicenter data
Department
Internal Medicine
Document Type
Conference Proceeding
Publication Title
Blood
Conference Name
American Society of Hematology (ASH) Annual Meeting
Conference Date
2025-12-06 - 2025-12-09
First Page
6964
DOI
10.1182/blood-2025-6964
Volume
146
Issue
Supplement 1
Publication Date
11-3-2025
Recommended Citation
Saleem, H., Adhikari, A., Khan, A., Ishaq, M., Khan, A. A., & Khan, A. (2025). Comparative long-term cardiovascular and hematologic outcomes of gemtuzumab ozogamicin containing regimens versus idarubicin containing regimens in acute promyelocytic leukemia: A propensity-matched analysis of real-world multicenter data. Blood, 146 (Supplement 1), 6964. https://doi.org/10.1182/blood-2025-6964
COinS